News

  • NN101 Dataset Available from NINDS Repository

    The dataset from the NN101 SMA project is now publicly available from the NINDS repository. Researchers interested in accessing this data should complete the NINDS Data Request Form and send it via email to the NINDS Clinical Research Liaison at: CRLiaison@ninds.nih.gov. 

  • NINDS Issues Press Release on NN102 SPRINT-MS Publication

    NINDS has issued a press release regarding the publication of the NN102 SPRINT-MS study results in the New England Journal of Medicine. The press release quotes NINDS Director Walter J. Kroshetz, MD, saying the NN102 SPRINT-MS findings “provide a glimmer of hope for people with a form of multiple sclerosis that causes long-term disability but does not have many treatment options.”

  • NN102 Primary Results published in New England Journal of Medicine

    The results of the NN102 SPRINT-MS have been posted online at the New England Journal of Medicine.  

  • NINDS Renews NeuroNEXT!

    The National Institute of Neurological Disorders and Stroke announced the renewal of the NeuroNEXT Network for an additional five years of funding. 

  • NeuroNEXT at the University of Iowa

    The University of Iowa highlighted NeuroNEXT achievements in two campus publications: Iowa Now provides an overview of the ways the Network is accelerating the clinical trials process, and The Daily Iowan focuses on the ways NeuroNEXT is bringing together clinical sites and coordinating centers to advance neurological trials. In addition, the College of Public Health at the University of…

  • Clinical Trials Methodology Course 2018 Webinar Series

    The Clinical Trials Methodology Course (CTMC) has begun their 2018 Webinar Series. These webinars are open to all. The course focues on the desing of early stage clinical trials for investigators focused on neurological illness and injury. The full scheduled may be viewed online: https://siren.network/training/ctmc/ctmc-webinars.  The NINDS Clinical Trials Methodology Course is supported by the NIH-NINDS:…

  • Neuro Central Podcast with Dr. Robert Fox, NN102 SPRINT-MS

    Neuro Central Podcast NC Talks featured an interview with Dr. Robert Fox, PPI of the NN102 SPRINT-MS study. Dr. Fox discussed trial results with the podcasters at the American Academy of Neurlogy’s 70th Annual Meeting in Los Angeles, CA. 

  • NeuroNEXT events at AAN 2018

    The American Academy of Neurology (AAN) Annual Meeting will begin April 21 in Los Angeles, CA. The following NeuroNEXT events and presentations will take place: Please visit the AAN Annual Meeting site for more information on the plenary sessions or emerging science program.  Related Projects:  NN102 SPRINT-MS NN103 Beat MG

  • NeuroNEXT represented at ASENT 2018 Annual Meeting

    Network successes and the five-year renewal application were presented at the 2018 Annual Meeting of the American Society for Experimental Neurotherapeutics poster session. The poster, presented March 9 at the meeting’s poster presentation and reception, concluded that NeuroNEXT has met all of its initial goals within the first 7-year funding period; that Network sites hae demonstrated their…

  • Editorial accompanying NN101 primary manuscript compliments NeuroNEXT network

    In the same issue where the NN101 SMA primary results were published, the Annals of Neurology also published an accompanying editorial with high praise for the Network. The authors noted that “NeuroNEXT is clearly trying to change the landscape of clinical trials in neurology, helping to empower the academic investigator to pursue research efforts that would otherwise be impossible.”